Cancer Research Technology Investor

Cancer Research Technology (CRT) develops and commercialises exciting new discoveries in cancer research. They’re the meeting point between academia and industry. Their deep understanding of both perspectives enables them to translate promising research into commercial propositions for the greatest patient benefit and maximum financial return.
CRT is uniquely placed to capitalise on the research and connections of their parent organisation Cancer Research UK, the world’s largest charitable funder of cancer research and the strong links they’ve established with leading clinical and academic institutions, pharmaceutical companies and biotechs worldwide.
CRT personnel are experienced, dedicated and highly motivated with an average length of service of nearly 6 years. The workforce is split between drug discovery and commercialisation for a comprehensive approach to getting breakthrough therapeutics to patients.
Industry: Personalized Medicine
Headquarters: London, England, United Kingdom
Founded Date: 2002
Employees Number: 101-250
Funding Status: N/A
Investor Type: N/A
Investment Stage: N/A
Number Of Exits: N/A

Visit Website
commercial@cancer.org.uk
@CRT_News
Register and Claim Ownership